Serum levels of the myokine irisin in relation to metabolic and renal function

European Journal of Endocrinology

Volumn 170, Issue 4, 2014, Pages 501-506

  Ebert, Thomas ^a   Focke, Denise ^a   Petroff, David ^a   Wurst, Ulrike ^a   Richter, Judit ^a   Bachmann, Anette ^a   Lössner, Ulrike ^a   Kralisch, Susan ^a   Kratzsch, Jürgen ^a   Beige, Joachim ^b   Bast, Ingolf ^c   Anders, Matthias ^c   Blüher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Klinikum St Georg   (Germany)

^c Clinical Trial Centre University of Leipzig ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IRISIN; UNCLASSIFIED DRUG;

AGE; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIASTOLE; DYSLIPIDEMIAS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; GLOMERULAR FILTRATION RATE; GLUCOSE INTOLERANCE; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX;

EID: 84899000059     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-1053     Document Type: Article

References (20)

1. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine 1996 334 292-295. (doi:10.1056/NEJM199602013340503)
2. Hou N & Luo JD. Leptin and cardiovascular diseases. Clinical and Experimental Pharmacology & Physiology 2011 38 905-913. (doi:10.1111/j.1440- 1681.2011.05619.x)
3. Hui X, Lam KS, Vanhoutte PM & Xu A. Adiponectin and cardiovascular health: an update. British Journal of Pharmacology 2012 165 574-590. (doi:10.1111/j.1476-5381.2011.01395.x)
4. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ et al. A pgc1-a-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012 481 463-468. (doi:10.1038/nature10777)
5. Richter J, Focke D, Ebert T, Kovacs P, Bachmann A, Lossner U, Kralisch S, Kratzsch J, Beige J, Anders M et al. Serum levels of the adipokine progranulin depend on renal function. Diabetes Care 2013 36 410-414. (doi:10.2337/dc12-0220)
6. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D & for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annals of Internal Medicine 1999 130 461-470. (doi:10.7326/0003-4819- 130-6-199903160-00002)
7. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J & Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of Internal Medicine 2003 139 137-147. (doi:10.7326/0003-4819-139-2-200307150-00013)
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
9. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012 36 S67-S74. (doi:10.2337/dc13-S067)
10. R Development Core Team. In R: A Language and Environment for Statistical Computing. Vienna, Austria.
11. Ripley B. In Modern Applied Statistics with S. New York: Springer.
12. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP & Landt M. Increased plasma leptin concentration in end-stage renal disease. Journal of Clinical Endocrinology and Metabolism 1997 82 847-850. (doi:10.1210/jcem.82.3.3817)
13. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. Journal of the American Society of Nephrology 2002 13 134-141. (doi:10.1097/01. ASN.0000032548.18973.0F)
14. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Blüher M, Stumvoll M & Fasshauer M. Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care 2007 30 2588-2592. (doi:10.2337/dc07-0275)
15. Philipp A, Kralisch S, Bachmann A, Lossner U, Kratzsch J, Blüher M, Stumvoll M & Fasshauer M. Serum levels of the adipokine zinc-a2-glycoprotein are increased in chronic hemodialysis. Metabolism 2011 60 669-672. (doi:10.1016/j.metabol.2010.06.019)
16. Sommer G, Ziegelmeier M, Bachmann A, Kralisch S, Lossner U, Kratzsch J, Bluher M, Stumvoll M & Fasshauer M. Serum levels of adipocyte fatty acid binding protein are increased in chronic haemodialysis. Clinical Endocrinology 2008 69 901-905. (doi:10.1111/j.1365-2265.2008.03277.x)
17. Stein S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M & Fasshauer M. Serum levels of the adipokine fgf21 depend on renal function. Diabetes Care 2009 32 126-128. (doi:10.2337/dc08-1054)
18. Pfau D, Bachmann A, Lössner U, Kratzsch J, Blüher M, Stumvoll M & Fasshauer M. Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 2010 33 171-173. (doi:10.2337/dc09-1351)
19. Wen M-S, Wang C-Y, Lin S-L & Hung K-C. Decrease in irisin in patients with chronic kidney disease. PLoS ONE 2013 8 e64025. (doi:10.1371/journal.pone. 0064025)
20. Zhang Y & Scarpace PJ. The role of leptin in leptin resistance and obesity. Physiology & Behavior 2006 88 249-256. (doi:10.1016/j.physbeh.2006. 05.038)